Piqray (alpelisib)

alpelisib · Novartis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Piqray (alpelisib), covering 2024-12-09 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world